From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
/in Hyperthermia, International Publications /von 2023-02-22 / Cancers (Basel) 2023 Feb;15(5)Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients
/in Cervical Cancer, Hyperthermia, International Publications /von 2023-01-20 / Medicine (Baltimore) 2023 Jan;102(3):e32727Commentary on „Systematic review about complementary medical hyperthermia in oncology“ by Liebl et al
/in Hyperthermia, International Publications /von 2022-10-14 / Clin Exp Med 2022 Nov;22(4):667-672Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field
/in Hyperthermia, International Publications /von 2022-06-04 / Cells 2022 Jun;11(11)Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2022-03-01 / Cancers (Basel) 2022 Mar;14(5)Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients
/in Cervical Cancer, Hyperthermia, International Publications /von 2022-01-27 / Cancers (Basel) 2022 Jan;14(3)Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2021-12-10 / Pathol Oncol Res 2021;27:1610048Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-1071
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de